Karen Eves

1.4k citations
22 papers · 383 · h-index 9

Impact in

    • Clostridium difficile and Clostridium perfringens research
    • HIV/AIDS drug development and treatment
    • Viral gastroenteritis research and epidemiology
    • HIV/AIDS Research and Interventions
  • Virology top 10%
    • HIV Research and Treatment

Papers in

    • HIV/AIDS drug development and treatment 9
    • Clostridium difficile and Clostridium perfringens research 7
    • Viral gastroenteritis research and epidemiology 5
    • Microscopic Colitis 5
    • Hepatitis B Virus Studies 4

Karen Eves

21 papers receiving 376 citations

Peers

Karen Eves
Comparison fields: 5 of 54
  • Infectious Diseases 293
  • Virology 64
  • Epidemiology 272
  • Critical Care and Intensive Care Medicine 27
  • Hepatology 36
Replace J.M. Bayas with:
J.M. Bayas Spain
Mirian Fernández-Alonso Spain
Tarmizi Thayaparan Malaysia
Emin Sami Arısoy Türkiye
Matt Zahn United States
G. Hawkins United Kingdom
J. Colaert Belgium
Roseline Thibeault Canada
K. Mohan United States
Evgeny Pinelis United States
Karen Eves relative to J.M. Bayas Spain J.M. Bayas's profile →
Citations per field
00.5×
J.M. Bayas · 1×
Citations per year

Countries citing papers authored by Karen Eves

Since Specialization
Citations

This map shows the geographic impact of Karen Eves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Eves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Eves more than expected).

Fields of papers citing papers by Karen Eves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Eves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Eves. The network helps show where Karen Eves may publish in the future.

Co-authors

The 25 scholars most cited alongside Karen Eves, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karen Eves Line = papers co-authored together Karen Eves links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2018144
2 200576
3 202133
4 200117
5 202115
6 201515
7 200711
8 202410
9 20209
10
Islatravir in combination with doravirine maintains HIV-1 viral suppression through 96 weeks
20208
11 20248
12 20067
13 20197
14 20166
15
Immunizing children to protect against the increasing risk of hepatitis A in adolescents and young adults in South Korea.
20044
16 20173
17
Field performance of VAQTA (inactivated, purified hepatitis a vaccine) in Chinese children in Jiangsu.
20043
18 20163
19
Islatravir safety analysis through week 48 from a phase 2 trial in treatment naive adults with HIV-1 infection
20202
20 20261

About Karen Eves

Karen Eves is a scholar working on Infectious Diseases, Epidemiology, Virology, Surgery and Emergency Medicine, having authored 22 papers that have together received 383 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), Clostridium difficile and Clostridium perfringens research (7 papers), HIV Research and Treatment (5 papers), Viral gastroenteritis research and epidemiology (5 papers), Microscopic Colitis (5 papers), HIV-related health complications and treatments (4 papers), Hepatitis Viruses Studies and Epidemiology (4 papers) and Hepatitis B Virus Studies (4 papers). The work is most often cited by research in Infectious Diseases (293 citations), Virology (64 citations), Epidemiology (272 citations), Critical Care and Intensive Care Medicine (27 citations) and Hepatology (36 citations). Karen Eves has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Marcus Dörr, Dale N. Gerding, Stephanie O. Klopfer, Galia Rahav, Dalya Güriş, Ciarán P. Kelly, Barbara J. Kuter, Misoo C. Ellison, Erik R. Dubberke and Christine Lee. Their work appears in journals such as Clinical Infectious Diseases, The Lancet HIV, Open Forum Infectious Diseases, Journal of the International AIDS Society and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact